Sonoco Releases 2024 Corporate Sustainability Report
Showcasing Sustainability Impact of Eviosys Transformation and Global Progress
HARTSVILLE, S.C., May 08, 2025 (GLOBE NEWSWIRE) -- Sonoco Products Company (NYSE: SON), a global leader in value-added sustainable packaging, today released its 2024 Corporate Sustainability Report, marking its transformation into a more sustainable packaging company following the acquisition of Eviosys, Europe's leading metal packaging manufacturer.
The union significantly enhances Sonoco's sustainability footprint, global reach and circular packaging portfolio with an additional 6,300 new employees and 45 facilities across Europe, the Middle East and Africa. The Company is now a global leader in metal and fiber packaging, serving some of the best-known consumer and industrial brands, yielding measurable results toward sustainable solutions that achieve our purpose of Better Packaging. Better Life. ®
Renewable energy and energy efficiency investments have helped Sonoco advance towards its Scope 1 and 2 greenhouse gas (GHG) emissions reduction targets of 25% by 2030 from the 2020 baseline. They include solar installations in Hartsville, S.C., Texas, and Italy; high-efficiency turbo blowers in Stainland, U.K. and Subang, Indonesia; and a new biogas boiler in Subang.
In total, 27 sustainability projects were put in place 2024, including the development of Sonoco's first-ever Virtual Purchase Power Agreement with ENGIE North America for 140 MW of wind energy capacity, scheduled to be operational by the end of 2025. These initiatives have helped reduce energy use by 9.6%, exceeding its original 8% goal for 2030. In addition, increased use of intermodal transport in North America reduced CO₂ emissions by approximately 2,400 metric tons annually.
The integration of Eviosys, now called Sonoco Metal Packaging EMEA, has further accelerated Sonoco's sustainability goals. In 2024, Eviosys achieved a 26.3% reduction in Scope 1 and 2 emissions from its 2020 baseline and earned an EcoVadis Platinum rating for the second year in a row, receiving a perfect score for environmental performance. Eviosys also installed five energy-efficient oxidizers at key sites, expected to reduce natural gas usage by 60% while eliminating solvent emissions.
'We're proud of the measurable progress made across the organization with the opportunity to expand impact with the addition of Eviosys,' said Scott Byrne, Sonoco Vice President of Global Sustainability. 'Together, we're building a truly global platform for circular innovation, climate action and sustainable growth.'
Sonoco's packaging portfolio continues to reflect a commitment to recyclability, consumer convenience and environmental stewardship. Innovations include Sonoco's Rigid Paper Container and lightweight, two-piece steel aerosols developed for compressed-air dusters — both advance circularity through smart, scalable solutions, alongside Eviosys' award-winning Ecopeel™, an easy-open food can that uses less material and cuts carbon emissions by 20%, and Horizon™, a lightweight overcap that enhances recyclability. Both Ecopeel and Horizon have been honored at the 2024 Oscar de l'Emballage Awards for excellence in sustainable packaging.
'Our Better Packaging. Better Life.® purpose continues to guide everything we do,' said Howard Coker, Sonoco President and CEO. 'Our teams are innovating, investing and collaborating across the globe to build a more sustainable future for our customers, communities and our planet.'
For more on the frameworks and guidelines supporting Sonoco's economic, environmental, social and governance standards, download the 2024 Corporate Sustainability Report: Reports | Sonoco Products Company.
About Sonoco
Founded in 1899, Sonoco (NYSE: SON) is a global leader in value-added, sustainable metal and fiber consumer and industrial packaging. The Company is now a multi-billion-dollar enterprise with approximately 23,400 employees working in 285 operations in 40 countries, serving some of the world's best-known brands. Guided by our purpose of Better Packaging. Better Life.,® we strive to foster a culture of innovation, collaboration and excellence to provide solutions that better serve all our stakeholders and support a more sustainable future. Sonoco was proudly named one of America's Most Trustworthy and Responsible Companies by Newsweek in 2025. For more information on the Company, visit our website at www.sonoco.com.
Contact:
Roger Schrum843-339-6018roger.schrum@sonoco.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Stratasys's Q1 Earnings Call: Our Top 5 Analyst Questions
Stratasys' first quarter results were well received by the market, as the company delivered better-than-expected revenue and improved profit margins despite ongoing softness in capital equipment spending. Management attributed the quarter's performance to resilient consumables demand, disciplined cost controls, and the continued strength of its recurring revenue model. CEO Yoav Zeif highlighted that consumables sales rose 7% sequentially, reflecting high utilization rates across the installed base, while CFO Eitan Zamir noted that the impact of cost-saving initiatives launched last year has helped offset lower product sales. Is now the time to buy SSYS? Find out in our full research report (it's free). Revenue: $136 million vs analyst estimates of $134.6 million (5.6% year-on-year decline, 1.1% beat) Adjusted EPS: $0.04 vs analyst estimates of $0.02 ($0.03 beat) Adjusted EBITDA: $8.17 million vs analyst estimates of $6.79 million (6% margin, 20.3% beat) The company reconfirmed its revenue guidance for the full year of $577.5 million at the midpoint Management raised its full-year Adjusted EPS guidance to $0.33 at the midpoint, a 6.3% increase EBITDA guidance for the full year is $47 million at the midpoint, above analyst estimates of $44.64 million Operating Margin: -9.1%, up from -17% in the same quarter last year Market Capitalization: $939.6 million While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Brian Drab (William Blair) asked about the impact of U.S. tariffs on products imported from Israel. CEO Yoav Zeif said tariffs apply to the cost of goods but are 'not material' at current levels. Brian Drab (William Blair) inquired about macroeconomic assumptions behind the second-half forecast. CFO Eitan Zamir explained guidance assumes a slightly stronger second half, driven by seasonality and focus on EBITDA, but acknowledged ongoing uncertainty in capital spending. Danny Eggerichs (Craig-Hallum) questioned trends in consumables demand and customer utilization. Zamir reported higher utilization rates, with expectations for consumables revenue to grow year-over-year as manufacturing applications increase. Danny Eggerichs (Craig-Hallum) asked about near-term capital allocation after the Fortissimo investment. Zeif said the primary use will be for inorganic growth, with a focus on acquisitions that fit Stratasys' recurring revenue and manufacturing strategy. Troy Jensen (Cantor Fitzgerald) probed the decline in R&D spend and competition at the low end of the market. Zamir emphasized R&D was refocused, not cut, while Zeif reiterated that Stratasys is committed to industrial-grade, high-end markets rather than commoditized prototyping. In upcoming quarters, the StockStory team will be watching (1) the pace of sequential revenue growth, particularly in consumables and high-value manufacturing markets; (2) deployment of capital from the Fortissimo investment, including any announced acquisitions; and (3) the adoption and performance of new products like the Neo800 Plus and advanced materials in key verticals. Execution on cost controls and recurring revenue expansion will also be critical signposts. Stratasys currently trades at $11.20, up from $9.73 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
The Top 5 Analyst Questions From Cogent's Q1 Earnings Call
Cogent's first quarter results were met with a negative market reaction after the company reported revenue below Wall Street's expectations, driven by ongoing churn in legacy Sprint contracts and continued efforts to exit low-margin services. CEO Dave Schaeffer openly acknowledged these headwinds, stating, 'We have churned the vast majority of undesirable revenue from the Sprint base,' which contributed to the year-on-year revenue decline. On the positive side, Cogent highlighted significant growth in its wavelength services and improvements in operating margin, reflecting realized cost savings from the Sprint integration and ongoing network optimization. Is now the time to buy CCOI? Find out in our full research report (it's free). Revenue: $247 million vs analyst estimates of $249.6 million (7.2% year-on-year decline, 1% miss) Adjusted EPS: -$1.09 vs analyst estimates of -$1.11 (1.4% beat) Adjusted EBITDA: $43.76 million vs analyst estimates of $69.87 million (17.7% margin, 37.4% miss) Operating Margin: -16.3%, up from -22.3% in the same quarter last year Market Capitalization: $2.3 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Josh (Goldman Sachs) asked about competitive dynamics in the wavelength segment and the outlook for corporate revenue growth. CEO Dave Schaeffer said competitors lack Cogent's coverage and provisioning speed, and expects corporate revenue to stabilize after churn completes by mid-year. Greg Williams (TD Cowen) inquired about the slower dividend growth and milestones to resume a higher pace. Schaeffer linked future dividend increases to deleveraging, stating that net leverage reduction is the key trigger. Alex Waters (Bank of America) questioned the trajectory of wavelength average revenue per user (ARPU) and timing of data center monetization. Schaeffer expects ARPU to stabilize around $1,900–$2,000 as higher-capacity sales rise and noted data center deals are progressing but lack a fixed timeline. Walter Piecyk (LightShed) asked if wavelength growth is limited by customer readiness or Cogent's own capacity. Schaeffer clarified that Cogent can provision up to 500 installs per month, but growth is currently paced by customer preparedness. Chris Scholl (UBS) asked about the confidence behind raising long-term growth targets and segment-level growth rates. Schaeffer cited improved visibility after Sprint churn and forecasted double-digit NetCentric growth and mid-single-digit corporate growth post-churn. In the coming quarters, the StockStory team will be watching (1) Cogent's ability to complete the churn of low-margin Sprint contracts and achieve a return to revenue growth, (2) the scaling and monetization of its wavelength and data center assets, and (3) continued improvement in adjusted EBITDA margins as cost savings are realized. Progress on data center sales or leases, as well as sustained strength in IPv4 leasing, will also be key markers of execution. Cogent currently trades at $47.66, down from $53.14 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it's free). The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Aurinia (AUPH) Surges 7.5%: Is This an Indication of Further Gains?
Aurinia Pharmaceuticals (AUPH) shares ended the last trading session 7.5% higher at $8.63. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.6% gain over the past four weeks. The sudden price rise can be attributable to positive investor expectations for Lupkynis, the company's sole marketed drug, which is approved for the treatment of adults with active lupus nephritis (LN). Lupkynis sales increased 25% year over year to $60 million during the first quarter of 2025. This biotechnology company is expected to post quarterly earnings of $0.18 per share in its upcoming report, which represents a year-over-year change of +800%. Revenues are expected to be $64.23 million, up 12.3% from the year-ago quarter. Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. For Aurinia, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on AUPH going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Aurinia is a member of the Zacks Medical - Drugs industry. One other stock in the same industry, Corcept Therapeutics (CORT), finished the last trading session 0.5% higher at $74.33. CORT has returned -4.7% over the past month. Corcept's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.23. Compared to the company's year-ago EPS, this represents a change of -28.1%. Corcept currently boasts a Zacks Rank of #3 (Hold). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aurinia Pharmaceuticals Inc (AUPH) : Free Stock Analysis Report Corcept Therapeutics Incorporated (CORT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
